News

The FDA approved dupilumab (Dupixent) for chronic spontaneous urticaria (CSU) in patients 12 years and older, the first new targeted drug for the inflammatory skin disease in over a decade, drugmakers ...
You’ve likely heard of well-known GLP-1 medications like Ozempic or Wegovy but some individuals are opting for specially made, compounded alternatives.
While JAZZ Pharmaceuticals JAZZ may not be a typical cannabis stock, it is the only company to market an FDA-approved drug ...
Ellen Behrend, VMD, PhD, MS, DACVIM (SAIM) explains the differences between bexagliflozin and velagliflozin, and how to determine if a patient is a good candidate ...
In the realm of male enhancement, few products have garnered as much attention as Penaril. This innovative supplement promises not just marginal improvements but a dramatic transformation in penile ...
CMND-100 is Clearmind’s proprietary MEAI-based oral drug candidate, developed as a potential breakthrough treatment for AUD. Unlike traditional treatment methods, CMND-100 is designed to offer a novel ...
Strategic collaboration brings next-gen AI pathology tools to the region ...
A Kentucky physician is facing up to three years in prison after distributing non-FDA approved semaglutide drugs, prosecutors ...
Antibiotic resistance is a major threat to human health. But experts say there are steps people can take to reduce the risk.
On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, ...
Actor Eric Dane, known for his roles in Grey's Anatomy and Euphoria, has been diagnosed with amyotrophic lateral sclerosis ( ...
Tirzepatide was approved in November 2023 by the US Food and Drug Administration (FDA) (Zepbound) and in the EU in June 2024 ...